Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 3330

Journal of Biotechnology & Biomaterials received 3330 citations as per Google Scholar report

Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • ResearchBible
  • China National Knowledge Infrastructure (CNKI)
  • Access to Global Online Research in Agriculture (AGORA)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • ICMJE
Recommended Journals
Share This Page

Jamal Alruwaili

Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Northern Border University, Arar Saudi Arabia

Biography

Dr. Jamal Alruwaili is currently working in Department of Medical Laboratory Technology, Faculty of Applied Medical Sciences, Northern Border University, Arar Saudi Arabia. Research interest - Chemistry, Organic Chemistry. He has a good track record in managing and developing local teams and competences as well as in growing a profitable business.
Publications

Sulfonylureas can Stimulate Insulin Release by Flip-Flop across Phospholipid Membranes

The design of new drugs and drug-delivery systems requires insight about how a drug interacts with the phospholipid bilayer. Sulfonylureas are used to treat type 2 diabetes mellitus because they stimulate insulin secretion from pancreatic β-cells. Two generations of Sulfonylurea drugs have been marketed to treat type II diabetes mellitus. Tolb... Read More»

Jamal Alruwaili

Research Article: J Biotechnol Biomater 2016, 6:218

DOI: 10.4172/2155-952X.1000218

Abstract Peer-reviewed Full Article Peer-reviewed Article PDF Mobile Full Article

Top